Hsieh, Chen, Chu, Chang, Tzeng, Huang, Lin, Chuang, Huang, Yeh, Chu, Ho, Huang, Chen, Yang, Lin, & Wu (2026). Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).. Journal of the American Heart Association.
Hsieh, Chen, Chu, Chang, Tzeng, Huang, et al. Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).. Journal of the American Heart Association. 2026; PMID: 42134976
Hsieh, Chen, Chu, et al. Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).[J]. Journal of the American Heart Association. 2026.
@article{hsieh2026,
author = {Hsieh and Chen and Chu and Chang and Tzeng and Huang and Lin and Chuang and Huang and Yeh and Chu and Ho and Huang and Chen and Yang and Lin and Wu},
title = {Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).},
journal = {Journal of the American Heart Association},
year = {2026},
note = {PMID: 42134976},
}
TY - JOUR AU - Hsieh AU - Chen AU - Chu AU - Chang AU - Tzeng AU - Huang AU - Lin AU - Chuang AU - Huang AU - Yeh AU - Chu AU - Ho AU - Huang AU - Chen AU - Yang AU - Lin AU - Wu TI - Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study). T2 - Journal of the American Heart Association PY - 2026 AN - PMID:42134976 ER -
Elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for cardiovascular disease. Despite available lipid-lowering therapies, lipid control remains suboptimal. Bempedoic acid offers a nonstatin oral treatment for hypercholesterolemia. However, real-world data in Asia are limited. The study aimed to investigate the effectiveness and safety of bempedoic acid in Taiwan.